The U.S. Nuclear Regulatory Commission is in the process of rescinding or revising guidance and policies posted on this webpage in accordance with Executive Order 14151 Ending Radical and Wasteful Government DEI Programs and Preferencing, and Executive Order 14168 Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government. In the interim, any previously issued diversity, equity, inclusion, or gender-related guidance on this webpage should be considered rescinded that is inconsistent with these Executive Orders.

SHINE Medical Technologies, LLC

Who:  SHINE Medical Technologies, LLC What:  Operating license application for SHINE Medical Isotope Production Facility When:  February 28, 2023 (NRC issued Safety Evaluation Report) Where:  Janesville, Wisconsin

For additional detail, see the following related pages:

• Application Documents
• Application Review Schedule
• Construction Inspection Reports
• Requests for Additional Information
• SHINE Medical Technologies, LLC Construction Permit Review
• Draft Supplemental Environmental Impact Statement
• Safety Evaluation Report - Related to the SHINE Medical Technologies, LLC Operating License Application for a Medical Radioisotope Production Facility
• Final Environmental Impact Statement Supplement Related to the Operating License for the SHINE Medical Isotope Production Facility

Contacts for the SHINE Medical Technologies, LLC. Operating License Application
Safety Project Manager	Michael Balazik (301) 415-2856
Environmental Project Manager	Lance Rakovan (301) 525-7280
Contact a Public Affairs Officer

Page Last Reviewed/Updated Friday, March 31, 2023